INR 4.97
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | 60.50 | 281.43 Thousand |
Cost of Revenue | - | - | - | - | - | 250.97 Thousand |
Gross Profit | - | - | - | - | 60.50 | 30.45 Thousand |
Operating Expenses | 880.00 | 2527.72 | 164.4 Thousand | 198.63 Thousand | 29.32 Thousand | 15.2 Thousand |
Selling, General and Administrative Expenses | 880.00 | 1048.57 | 2027.89 | 2289.89 | 2325.87 | 2509.81 |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 880.00 | 2527.72 | 164.4 Thousand | 198.63 Thousand | 29.32 Thousand | 266.18 Thousand |
Operating Income | -880.00 | -2531.72 | -164.31 Thousand | -194.95 Thousand | -10.23 Thousand | 19.57 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | 15.87 | 309.83 | 226.11 | 377.11 |
Earnings before Tax | -29.66 Thousand | -29.74 Thousand | -192.3 Thousand | -226.56 Thousand | -57.13 Thousand | 2013.35 |
Net Income | -29.66 Thousand | -29.74 Thousand | -192.28 Thousand | -226.86 Thousand | -56.91 Thousand | 1636.24 |
Earnings Per Share Basic | -3.01 | -3.01 | -19.49 | -22.99 | -5.77 | 0.17 |
Earnings Per Share Diluted | -3.01 | -3.01 | -19.49 | -22.99 | -5.77 | 0.17 |
Weighted Average Shares Outstanding | 9856.00 | 9867.00 | 9865.00 | 9867.00 | 9863.00 | 9867.00 |
Weighted Average Shares Outstanding (Diluted) | 9856.10 | 9867.29 | 9867.29 | 9867.29 | 9867.29 | 9867.29 |
Gross Margin | - | - | - | - | 1.00 | 0.11 |
EBIT Margin | - | - | - | - | -149.06 | 0.08 |
Profit Margin | - | - | - | - | -940.71 | 0.01 |
EBITDA | -1683.02 | -1897.42 | -163.54 Thousand | -194.02 Thousand | -9018.23 | 21.15 Thousand |
Earnings Before Tax Margin | - | - | - | - | -169.23 | 0.07 |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 1746.75 | 225.00 | 485.27 | 388.11 | 388.11 | 779.80 |
Selling, General and Administrative Expenses | - | 225.00 | 225.00 | 215.00 | 215.00 | 286.29 |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 1746.75 | 225.00 | 485.27 | 388.11 | 388.11 | 779.80 |
Operating Income | -2210.63 | -225.00 | -593.84 | -511.47 | -511.47 | -640.19 |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | -368.85 | - | - | - | - |
Earnings before Tax | -29.66 Thousand | -7465.30 | -7465.30 | -7368.14 | -7368.14 | -7408.75 |
Net Income | -29.66 Thousand | -7465.30 | -7465.30 | -7368.14 | -7368.14 | -7408.75 |
Earnings Per Share Basic | - | -0.76 | -0.76 | -0.75 | -0.75 | -0.75 |
Earnings Per Share Diluted | - | -0.76 | -0.76 | -0.75 | -0.75 | -0.75 |
Weighted Average Shares Outstanding | 9856.00 | 9822.00 | 9822.00 | 9890.00 | 9890.00 | 9848.00 |
Weighted Average Shares Outstanding (Diluted) | 9856.10 | 9822.08 | 9822.08 | 9890.12 | 9890.12 | 9848.37 |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | - | -461.95 | -461.95 | -379.57 | -379.57 | -474.38 |
Earnings Before Tax Margin | - | - | - | - | - | - |
MEDVF
BNORDIK-CSE
MLEDU
8260
603519
CABB